The use of myeloperoxidase as a risk marker for atherosclerosis

被引：26

作者：

Nambi V. ^{[1
]}

机构：

[1] Section of Cardiology, Baylor College of Medicine, Houston, TX 77030

来源：

Current Atherosclerosis Reports | 2005年 / 7卷 / 2期

关键词：

Acute Coronary Syndrome; Endothelial Dysfunction; Vulnerable Plaque; Arterioscler Thromb Vasc Biol; Major Adverse Cardiovascular Event;

D O I：

10.1007/s11883-005-0035-z

中图分类号：

学科分类号：

摘要：

The mechanisms of atheroma formation and their ensuing complications and methods by which these can be detected have been the focus of several in vitro, in vivo, and clinical studies. Myeloperoxidase (MPO) is a microbicidal hemoprotein that serves as a part of the neutrophils' armory in host defense. However, the oxidation products generated by MPO have now been shown to be related to various stages of atheroma development. MPO and its oxidant products have been shown to be capable of modifying low-density lipoprotein cholesterol and to be enriched in human atheromas and rupture-prone plaques. Clinical studies have suggested an association between levels of MPO and the presence of coronary artery disease and endothelial dysfunction, and have shown a possible additional role to troponin in patients with chest pain. Copyright © 2005 by Current Science Inc.

引用

页码：127 / 131

页数：4

共 44 条

[21]

Schmitt D., Shen Z., Zhang R., Et al., Leukocytes utilize myeloperoxdase generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum, Biochemistry, 38, pp. 16904-16915, (1999)

[22]

Thukkani A.K., McHowat J., Hsu F.F., Et al., Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions, Circulation, 108, pp. 3128-3133, (2003)

[23]

Zhang R., Brennan M.L., Fu X., Et al., Association between myeloperoxidase levels and risk of coronary artery disease, JAMA, 286, pp. 2136-2142, (2001)

[24]

Farb A., Burke A.P., Tang A.L., Et al., Coronary plaque erosion without rupture into a lipid core

[25]

a frequent cause of coronary thrombosis in sudden coronary death, Circulation, 93, pp. 1354-1363, (1996)

[26]

Vissers M.C., Pullar J.M., Hampton M.B., Hypochlorous acid causes caspase activation and apoptosis or growth arrest in human endothelial cells, Biochem. J., 344, pp. 443-449, (1999)

[27]

Sugiyama S., Kugiyama K., Aikawa M., Et al., Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: Involvement of myeloperoxidase mediated oxidant in plaque erosion and thrombogenesis, Arterioscler. Thromb. Vasc. Biol., 24, pp. 1309-1314, (2004)

[28]

Brennan M.L., Penn M.S., Van Lente F., Et al., Prognostic value of myeloperoxidase in patients with chest pain, N. Engl. J. Med., 349, pp. 1595-1604, (2003)

[29]

Baldus S., Heeschen C., Meinertz T., Et al., Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes, Circulation, 108, pp. 1440-1445, (2003)

[30]

Abu-Soud H.M., Hazen S.L., Nitric oxide is a physiological substrate for mammalian peroxidases, J. Biol. Chem., 281, (2000)

← 1 2 3 4 5 →